Mucopolysaccharidosis Market and the Rising Need for Advanced Rare Disease Treatments
Mucopolysaccharidosis (MPS) is a rare group of inherited metabolic conditions caused by enzyme deficiencies that prevent the normal breakdown of glycosaminoglycans within cells. As these compounds accumulate throughout the body, patients may experience severe complications involving the bones, heart,...
SPARK Website
عربي